Explore more topics
SEC reporting owner

MILLENNIUM PHARMACEUTICALS INC SEC insider disclosures

Explore MILLENNIUM PHARMACEUTICALS INC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001002637
Issuers
5
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

Molecular Templates, Inc.0001183765MTEMNoNo
Myovant Sciences Ltd.0001679082MYOVNoNo
Ovid Therapeutics Inc.0001636651OVIDNoNo
Day One Biopharmaceuticals, Inc.0001845337DAWNNoNo
Calithera Biosciences, Inc.0001496671CALANoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.